Gastrointestinal and pancreatic tumors with Indication for EUS-FNA
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Mass (Pancreatic tumor or lymph node swelling or submucosal tumor) of 7mm or more. Requirement of pathological or cytological diagnosis for treatment. Informed consent voluntary patient himself was obtained in writing.
Exclusion criteria
Exclusion criteria: Mass of 6mm or less. High riks for complications. Severe dysfunction in other organs. Inability to obtain informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoints: Satisfactory simpling rate for histological diagnosis, histopathological diagnositic rate,rate of adverse event. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: technical success rate | — |
Countries
Japan
Contacts
Asahikawa medical college Department of Medicine Division of Gastroenterology and Hematology / Oncology